Interleukin Related Inhibitors

IL-1

IL-2

IL-3

IL-4

IL-5

IL-6

IL-8

IL-10

IL-12

IL-13

IL-15

IL-17

IL-23

IL-7

IL-33

IL-22

Interleukin Related Degraders, Inducers, Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	IL-1	IL-2	IL-3	IL-4	IL-5	IL-6	IL-8	IL-10	IL-12	IL-13	IL-15	IL-17	IL-23	IL-7	IL-33	IL-22	Purity
Resatorvid						IL-6, IC₅₀: 1.3 nM											99.95%
Disulfiram	IL-1β																99.78%
Polyinosinic-polycytidylic acid										IL-13		IL-17A					99.40%
Raleukin	IL-1																99.40%
Deucravacitinib									IL-12				IL-23				99.87%
Icotrokinra													IL-23, Kd: 7.1 pM				99.89%
INF 195	IL-1β																99.55%
Dupilumab		IL-2		IL-4						IL-13							≥99.2%
Oxidopamine hydrobromide	IL-1β																99.95%
Tocilizumab						IL-6											99.67%
Apilimod				IL-4	IL-5		IL-8		IL-12				IL-23				99.80%
Oxidopamine hydrochloride	IL-1β																99.91%
LMT-28						IL-6											98.93%
Secukinumab												IL-17A					≥99.20%
Theophylline						IL-6		IL-10									99.89%
Sodium metatungstate	IL-1β
Benzbromarone	IL-1β						IL-8										99.81%
Hydrocortisone hemisuccinate			IL-3, IC₅₀: 21.4 μM			IL-6, IC₅₀: 6.7 μM											99.83%
Fibrinogen (Bovine)							IL-8
JTE-607						IL-6	IL-8	IL-10									99.27%
LY3509754												IL-17					99.65%
SC144						IL6-beta											98.50%
Oxazolone				IL-4						IL-13							≥98.0%
Risankizumab													IL-23, Kd: <10 pM				99.37%
Ixekizumab												IL-17					98.90%
Lysophosphatidylcholines	IL-1β																≥99.0%
Apilimod mesylate				IL-4	IL-5		IL-8		IL-12				IL-23				99.83%
ODN 2216									IL-12
Ustekinumab									IL-12				IL-23				98.42%
Muscone	IL-1β					IL-6											≥98.0%
APY0201									IL-12				IL-23				99.93%
Bimekizumab												IL-17A IL-17F
IL-17A antagonist 1												IL-17A, IC₅₀: 1.14 nM IL-17A, Kd: 0.66 μM					99.74%
Lebrikizumab										IL-13							99.90%
Diacerein	IL-1β																98.78%
Astegolimab															ST2		98.96%
Vidofludimus												IL-17					99.11%
Guselkumab													IL-23, IC₅₀: .06 nM				98.97%
Diallyl Trisulfide						IL-6	IL-8
Neochlorogenic acid	IL-1β																99.77%
Prednisone acetate				IL-4				IL-10				IL-17					99.92%
Semapimod tetrahydrochloride	IL-1β					IL-6											98.43%
Mulberroside A	IL-1β					IL-6											99.86%
Tryptanthrin		IL-2				IL-6		IL-10	IL-12								99.89%
Golimumab	IL-1					IL-6											99.71%
TMI-1	IL-1β					IL-6											99.59%
Daclizumab		IL-2
Ginsenoside Rc	IL-1β																≥98.0%
Inbakicept											IL-15Rα						98.95%
Y-320											IL-15	IL-17					99.74%
Deltamethrin	IL-1β																99.93%
Sarilumab						IL-6											98.37%
AF12198	IL1R1, IC₅₀: 8 nM																99.75%
BRD6989								IL-10									99.56%
Broussonin E	IL-1β					IL-6		IL-10									98.18%
AX-024						IL-6		IL-10				IL-17A					99.29%
Smurf1-IN-A01	IL-1β																99.81%
Thiabendazole	IL-1β					IL-6		IL-10		IL-13							99.77%
Elobixibat						IL-6											99.91%
Tralokinumab										IL-13
IL-17 modulator 4												IL-17					99.00%
Madecassic acid	IL-1β					IL-6											99.23%
Peimine	IL-1 IL-1β					IL-6		IL-10									99.40%
Fusidic acid sodium salt	IL-1β IL-1					IL-6											99.64%
Ossirene	IL-1β							IL-10									≥98.0%
Eucalyptol	IL-1β																≥98.0%
Ginsenoside Rh1	IL-1β					IL-6											≥98.0%
Ac-YVAD-CHO	IL-1β																98.97%
Nidanilimab (Nadunolimab)	IL-1α IL-1β																99.90%
Lusvertikimab														IL7R			99.41%
NecroX-7						IL-6											99.69%
YQ128	IL-1β																99.83%
Reslizumab					IL-5, IC₅₀: 91.1 pM												99.40%
Veledimex	IL-1								IL-12								98.45%
Elsilimomab						IL-6, IC₅₀: 1.4 nM											98.44%
SC144 hydrochloride						IL6-beta											99.34%
Benralizumab					IL-5Rα												99.1%
Elubrixin tosylate							IL-8										99.78%
Sonelokimab												IL-17A IL-17F					99.81%
Pectolinarin						IL-6	IL-8										99.89%
Pinostrobin	IL-1β																99.98%
Briakinumab									IL-12				IL-23
UF010						IL-6											99.84%
RCGD423						IL6-beta											99.66%
Olokizumab						IL-6
Taurohyodeoxycholic acid sodium						IL-6											99.60%
RO2959 monohydrochloride		IL-2															98.21%
IL-15-IN-1											IL-15, IC₅₀: 0.8 μM						99.42%
Etokimab			IL-3														99.90%
Rilonacept	IL-1
Gamma-glutamylcysteine TFA	IL-1β					IL-6		IL-10
IL-17A modulator-1												IL-17A, pIC₅₀: 8.2					99.01%
IL-17 modulator 3												IL-17					99.53%
Ordesekimab											IL-15
Cendakimab										IL-13							99.96%
Hesperetin 7-O-glucoside	IL-1β															IL-22	98.08%
Kaempferol 3-O-β-D-glucuronide	IL-1β							IL-10									99.41%
N-Acetyl-L-tryptophan	IL-1β																99.38%
VGX-1027	IL-1β							IL-10									99.76%
AX-024 hydrochloride						IL-6		IL-10				IL-17A					99.75%
L6H21						IL-6, IC₅₀: 8.59 μM											99.46%
YM-90709					IL-5												99.77%
Ginsenoside F3		IL-2 IL-2		IL-4 IL-4				IL-10 IL-10									99.84%
GIBH-130	IL-1β, IC₅₀: 3.4 nM																99.87%
Fosfenopril	IL-1β					IL-6											99.89%
iNOs-IN-1						IL-6											99.83%
SP4206		IL-2, Kd: 70 nM															98.55%
Nepetin	IL-1					IL-6	IL-8										99.51%
Armillarisin A	IL-1β			IL-4													99.80%
Balsalazide	IL-1					IL-6 IL-6											99.34%
Naphazoline hydrochloride	IL-1β			IL-4		IL-6											98.12%
IL-17A antagonist 3												IL-17A					98.55%
S7						IL-6											99.12%
Erepdekinra												IL-17					98.60%
IL-17A modulator-2												IL-17A, pIC₅₀: 8.3					99.07%
Rosarin	IL-1																99.94%
Methylthiouracil						IL-6											≥98.0%
(R)-IL-17 modulator 4												IL-17					99.57%
Deacetylasperulosidic Acid		IL-2															99.86%
Suplatast (Tosilate)		IL-2			IL-5					IL-13							98.33%
7,3',4'-Tri-O-methylluteolin	IL-1β					IL-6											99.28%
Satralizumab						IL-6											99.82%
Theophylline (Standard)						IL-6		IL-10									99.99%
Anti-inflammatory agent 35						IL-6											99.77%
PF-4878691	IL-1β	IL-2				IL-6	IL-8										99.89%
Efineptakin alfa														IL7R			99.70%
Anti-Mouse IL-10 Antibody (JES5-2A5)								IL-10
Anti-Mouse IL-1R Antibody (JAMA-147)	IL-1
Naphazoline nitrate	IL-1β			IL-4		IL-6											≥98.0%
Piperonylic acid						IL-6		IL-10									99.91%
Di-O-methyldemethoxycurcumin						IL-6
SU5201		IL-2															99.45%
HMGB1-IN-1	IL-1β																99.37%
Balsalazide sodium hydrate						IL-6											99.61%
Sodium thiocyanate, GR, 99%						IL-6		IL-10									99.14%
Tyrphostin A1									IL-12								98.96%
Remtolumab												IL-17A					99.24%
IL-17 modulator 1 disodium												IL-17					99.46%
Lys-D-Pro-Thr	IL-1																99.23%
NO-prednisolone								IL-10									≥99.0%
RP-54745	IL-1																99.79%
Brazikumab													IL-23, Kd: 0.138 nM
β-Anhydroicaritin						IL-6		IL-10									99.09%
Luteolin-4'-O-glucoside					IL-5												99.05%
Isoforskolin	IL-1β					IL-6	IL-8										≥98.0%
BML-280	IL-1β						IL-8										99.64%
Negletein	IL-1β, IC₅₀: 10.8 nM																99.55%
RO2959 hydrochloride		IL-2
Elubrixin							IL-8
Perakizumab												IL-17A					99.79%
Anti-Mouse IL-1b Antibody (B122)	IL-1
Efmarodocokin alfa																IL-22
Gumokimab												IL-17A					98.95%
Madecassic acid (Standard)	IL-1β					IL-6
IL-2-IN-1		IL-2, IC₅₀: 1978 nM															99.95%
BAA473	IL-1																98.93%
NFAT Transcription Factor Regulator-1		IL-2, IC₅₀: 182 nM															99.37%
Abrezekimab										IL-13
Y13g dihydrochloride						IL-6											99.89%
IX 207-887	IL-1	IL-2															98.96%
Hydrangenol						IL-6											99.33%
IL-17 modulator 4 sulfate												IL-17
Veledimex racemate	IL-1																≥98.0%
BMS-986251												IL-17, EC₅₀: 24 nM
Theophylline sodium glycinate						IL-6		IL-10
A-9758												IL-17A	IL-23
Clazakizumab						IL-6
Vopikitug		IL-2
Theophylline monohydrate						IL-6		IL-10
Tagraxofusp			IL-3
Naphazoline	IL-1β			IL-4		IL-6
Anti-inflammatory agent 17						IL-6, IC₅₀: 8.254 μM
Lipoxin A4-d₅							IL-8
Akt/NF-κB/MAPK-IN-1	IL-1β					IL-6
VEGFR-2-IN-40						IL-6
eeAChE-IN-3						IL-6, IC₅₀: 0.57 μM
YSY01A						IL6-beta
Sugiol	IL-1β
Smad2/3-IN-2				IL-4, IC₅₀: 20 nM
Lck Inhibitor III		IL-2
Coelonin	IL-1β					IL-6
Ginsenoside Rh1 (Standard)	IL-1β					IL-6
Smad2/3-IN-1				IL-4, IC₅₀: 20 nM
JAK1/2-IN-1				IL-4, IC₅₀: 136.5 nM						IL-13, IC₅₀: 19.1 nM
Lyn peptide inhibitor TFA			IL-3		IL-5
HB-107							IL-8
NLRP3-IN-24	IL-1β					IL-6
IL-17A inhibitor 2												IL-17
NLRP3-IN-54	IL-1β, IC₅₀: 0.805 μM
Diacerein (Standard)	IL-1β
Myelopeptide-2		IL-2
DPP-4-IN-8	IL-1β					IL-6
Ac-YVAD-CHO acetate	IL-1β
Ppc-1		IL-2
IL-17-IN-2												IL-17
Lyn peptide inhibitor			IL-3		IL-5
IL-17 modulator 6												IL-17, pIC₅₀: 9.1
Balsalazide-d₄						IL-6
IL-1β-IN-1	IL-1β
BMP-4						IL-6
TNF-α-IN-10						IL-6
AVP-13358				IL-4	IL-5					IL-13
LM-021	IL-1β					IL-6
CK-119	IL-1
HSP90-IN-31	IL-1β					IL-6
ARN14494	IL-1β
RC529-MDP						IL-6
NLRP3-IN-42	IL-1β
MR2938	IL-1β					IL-6
PDE4-IN-8				IL4, IC₅₀: 36.33 nM						IL-13, IC₅₀: 4.04 nM
Antiflammin-1	IL-1β
IL-17 modulator 1												IL-17
Tibulizumab												IL-17A, Kd: 14 pM
Theophylline sodium acetate						IL-6		IL-10
Semapimod	IL-1β					IL-6
Shizukaol B	IL-1β
Navepdekinra												IL-17A
M199						IL-6	IL-8
Hidrosmin	IL-1β
Immuno modulator-1		IL-2
Triptoquinone B	IL-1
Dectrekumab										IL-13
YM-I-26	IL-1β							IL-10
NOD1-RIPK2-IN-1							IL-8
Y13g						IL-6
RPR-106541				IL-4	IL-5
R-348 choline						IL-6		IL-10
HPK1-IN-43		IL-2
E5090	IL-1
Dersalazine sodium												IL-17
Veledimex (S enantiomer)	IL-1																99.52%

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4